Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Policy decisions about the human genomeW Allen, B Goldspiel, L J KirchdoerferCancer|November 1, 1993
Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitroS M Hahn, J E Liebmann, J Cook, et al.Gynecologic Oncology|June 1, 1996
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovaryE Reed, G Sarosy, E Kohn, et al.Cancer|August 1, 1993
A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinomaJ L Grem, N McAtee, F Balis, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
Phase I study of Taxol, doxorubicin, plus granulocyte-colony stimulating factor in patients with metastatic breast cancerJ S Fisherman, M McCabe, M Noone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancerL L Herscher, S M Hahn, G Kroog, et al.Human Gene Therapy|July 1, 1994
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancerJ A O'Shaughnessy, K H Cowan, A W Nienhuis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patientsJ A O'Shaughnessy, A M Denicoff, D J Venzon, et al.Cancer Research|February 1, 1996
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancersE C Kohn, E Reed, G Sarosy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transductionW D Figg, K A Cole, E Reed, et al.Pageof 3